F18.9 Inhalant use, unspecified

Name of the Condition

• Common Name: Inhalant Use Disorder
• Medical Term: Inhalant Use, Unspecified

Summary

Inhalant use, unspecified, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, without specifying the severity or presence of a disorder. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to acute intoxication, dependence, or other substance-related health issues. Inhalant use may result in significant physical and psychological harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment or memory issues.

Diagnosis

Clinical evaluation including a detailed history of inhalant use, physical examination, and assessment of symptoms. Laboratory tests may be used to detect substance exposure, though specific inhalant detection can be challenging.

Treatment Options

Treatment may involve behavioral therapies, such as cognitive-behavioral therapy, to address misuse patterns. Supportive care for acute intoxication or withdrawal symptoms may be necessary. In some cases, medication-assisted treatment or referral to substance use disorder programs is recommended.

Prognosis and Follow-Up

Prognosis depends on the frequency and duration of use, as well as the presence of co-occurring disorders. Regular follow-up is important to monitor for relapse, manage withdrawal symptoms, and address any long-term health effects.

Complications

• Respiratory distress or lung damage.
• Neurological issues, including cognitive impairment or seizures.
• Cardiovascular problems, such as irregular heart rhythms.
• Risk of sudden sniffing death due to cardiac or respiratory arrest.

Lifestyle & Prevention

• Avoiding exposure to inhalant products, especially for at-risk individuals.
• Educating communities about the dangers of inhalant misuse.
• Providing alternative activities or support for adolescents.
• Ensuring proper storage and disposal of household chemicals.

When to Seek Professional Help

Seek help if inhalant use is frequent, causing impairment, or if withdrawal symptoms (e.g., tremors, anxiety) occur. Immediate medical attention is needed for severe symptoms like difficulty breathing or loss of consciousness.

Tips for Medical Coders

Document the clinical context of inhalant use, including whether it is acute, chronic, or unspecified. Ensure the code aligns with the provider's documentation of misuse patterns or related health issues. Note any comorbidities or complications to support accurate coding.